SEVEN EIGHT CAPITAL, LP - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 162 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2021$674,000
-66.8%
14,100
-69.9%
0.06%
-86.1%
Q1 2021$2,031,0000.0%46,8190.0%0.47%
+1.1%
Q4 2020$2,031,00046,8190.46%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2021
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders